Download presentation
Presentation is loading. Please wait.
Published byTimothy Patterson Modified over 9 years ago
1
Kidney, Pancreas & Intestinal Transplantation Mr James Gilbert Consultant Transplant & Vascular Access Surgeon
3
A Lot to squeeze in!
5
Kidney Transplantation
7
54,824 adults on dialysis in UK Represents 108 per million population (pmp) 6891 new starters in 2012 Continues to rise year on year Figure 2.2. Growth in prevalent patients by treatment modality at the end of each year 1997–2012
8
But dialysis is not great long term: 1 Yr Survival5 Yr Survival10 Yr Survival Polycystic Kidney Disease94%70%42% Glomerulonephritis88%58%37% Hypertension77%33%14% Diabetes71%29%11%
9
Transplant is a ‘treatment option’ Ultimate form of RRT Improves quality and quantity of life Allows normal diet and fluid intake Progressive reversal of anaemia & bone disease All patients with ESRF should be considered Not necessarily for everyone There is an alternative (HD, PD, Conservative) Transplants don’t last forever
10
Kidney Transplant Rates
11
Living Transplant Rates
12
Life enhancing or life saving? Doubles life expectancy (20 years vs. 10 years overall) Cost of transplant = 1 year dialysis costs!
21
Pancreas Transplantation
22
The insulin-dependent diabetic is: 25 times more prone to blindness 17 times more prone to kidney disease 5 times more often afflicted with gangrene Twice as often afflicted with heart disease Has a life expectancy 1/3 less than that of the general population
23
Pancreas Transplantation: Only treatment that reliably offers type 1 diabetics: – Insulin independence – Normal glucose metabolism – Normal Diet – Ameliorate secondary complications DM – Improved quality and quantity of life Now associated with improved outcomes Viewed more enthusiastically rather than sceptically
24
UK pancreas and islet activity
25
Pancreas Donors by type
26
2013 Pancreas & islet Tx by donor type & centre
27
Any pancreas program should: Have overall low morbidity & mortality Eliminate need for insulin and BM monitoring Eliminate hypoglycaemic events Create a euglycaemic state with pre and postprandial sugars comparable to non diabetics Achieve HbA1c levels comparable to those in non diabetics
28
Best results achieved when: Have a ‘perfect’ donor – Young, slim DBD Donor Have a ‘perfect’ recipient – Pre-dialysis and slim ‘Perfect’ retrieval and short cold ischaemic time No complications Ideals rarely possible but must strive for ‘perfection’ due to sensitive nature of the pancreas Hence fussy pancreas transplant surgeons
29
Donor considerations Age: <55 (DBD) <50 (DCD) Girth < 90cm / BMI < 27 ‘Good health’ history Minimal ‘down time’ Minimal fatty infiltration or fibrosis of parenchyma Short cold ischaemic time
30
Pancreas donor age
31
Pancreas donor BMI
32
Surgical options Simultaneous Pancreas & Kidney (SPK) Pancreas after Kidney (PAK) Pancreas Alone (PAT) (Islets) – Radiological guided infusion into portal system
33
Indications SPKPAKPTA IDDM Hyperlabile IDDM Diabetic Nephropathy: Cr Clearence <20 ml/min Stable Kidney allograft function >2 diabetic complications Significantly impaired QOLProgressive diabetic complications Hypoglycaemic Unawareness (3 rd Part assistance needed) Hyperlabile IDDM after kidney transplant Acceptable kidney function Significantly impaired QOL
34
Portal vein onto IVC Exocrine drainage to proximal SB Y-Graft onto distal aorta / RCIA Kidney onto left iliac vessels SPK Transplant
35
PAK / PA Transplant Recent move to bladder drainage (2011) Consequence of inferior outcomes c/w SPK – 70% 1 yr survival 2010/11 Use urinary amylase as a measure of function Higher morbidity for the patient but ? Better graft survival (time will tell)
36
Common peri-operative problems Bleeding Thrombosis Graft Pancreatitis Delayed Graft Function Prolonged ileus / exacerbation gastroparesis – Need for TPN Sepsis – Peri-pancreatic collections – Pancreatic leaks
37
Graft Pancreatitis Appears during the first few days and common Usually self limiting Pain and tenderness at the graft site Associated peri-pancreatic oedema / collection High drain amylase Usually result of: – Ischaemic reperfusion injury – More common in marginal organ, DCD & larger recipient – Handling – Infection
38
Oxford Pancreas Programme Activity & Outcome Data April 2011 – Mar 2013
39
Transplant type and Donor type DBDDCDTotal SPK11514129 PAK314 PTA191130 Total13726163
40
Transplant Outcomes (1 Year) Transplant Type Insulin Independence Dialysis Independence Deaths SPK115/129122/1297/129 PAK3/4-0/4 PTA26/30-1/30 Total 144/163 (88%) 122/129 (95%) 8/163 (4.9%) 3 deaths in first 30 days: 1 with ARDS, 2 Cardiac Arrest.
41
Mortality Comparison 2 times more likely to die each year on waiting list than in first year after transplant
42
SPK outcomes 2007 – 2012 (DBD)
43
Isolated Pancreas outcomes 2007 – 2012 (DBD)
44
Pancreas Outcomes 2007 – 2012 (DCD)
45
Cause of graft loss 2007 - 2012
46
Intestinal Transplantation
47
Intestinal Transplantation - Types Isolated Small Bowel Multivisceral Whole Liver & Small Bowel Modified Multivisceral
48
Indications Presence of irreversible intestinal failure with – Impaired venous access for TPN (reduced to the last two suitable veins for placement of the feeding catheter) – Progressive fibrotic liver disease (usually from TPN) – Life threatening episodes of catheter related sepsis Broadly two situations that lead to intestinal failure: 1.Short gut syndrome (less than 40 cm in length) 2.Non functioning bowel
49
Isolated Small Bowel Multivisceral
50
Liver & Small Bowel
53
The Problem: Difficult Abdominal Wall Closure A Solution: Abdominal Wall Transplant
54
The sentinel skin graft Novel concept for graft surveillance Skin more allo-sensitive and rejects before organs Early cases suggest a lead time of 2 weeks Provides option for PAT / intestinal transplant where organ monitoring very difficult Based on vascularised skin island from forearm 2 cases to date Number of re-do PAT patients being listed for SSG
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.